The global macular degeneration treatment market size was valued at USD 10.06 billion in 2024 and it is projected to reach ...

People who are of European descent may be more at risk of age-related macular degeneration than those of African or Hispanic ...

DelveInsight's 'Dry Age-Related Macular Degeneration Pipeline Insight 2025' report provides comprehensive global coverage of ...

Macular degeneration is a leading cause of vision loss for people over 50, but there are ways to help protect your eyesight.

Introduction The eye's macula is impacted by macular degeneration, a neurodegenerative condition. Macular degeneration will cause loss of centr ...

Medication is sometimes necessary to treat eye conditions and vision problems. Of course, this is highly dependent on the ...

The world of entertainment has been graced with the remarkable talent of 90-year-old Dame Judi Dench for decades, but the ...

The team enrolled 19 patients over age 50 with advanced wet AMD and divided subjects into five groups that received different doses of the gene. “Even at the highest dose, the treatment was quite safe ...

The Gonzales Lab at UNR Med, led by Albert Gonzales, Ph.D., assistant professor of physiology and cell biology, spearheaded ...

Objective To assess the incremental cost and cost-effectiveness of continuous and discontinuous regimens of bevacizumab (Avastin) and ranibizumab (Lucentis) for neovascular age-related macular ...

Intermediate AMD: If you have intermediate AMD in one or both eyes, AREDS 2 supplements may help prevent it from turning into late-stage AMD, which causes significant vision loss. Late AMD in One Eye: ...

Pegcetacoplan (Syfovre) is now approved in Australia for treating geographic atrophy (GA) secondary to age-related macular ...